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The complex interaction between gene expressions and environmental factors plays a key 
role in the pathogenesis of various diseases, including neurodevelopmental disorders (Lenroot & 
Giedd, 2008). This study aimed to evaluate first, the magnitude of association between placental 
gene Methyl-CpG Binding Protein 2 (MeCP2) and intellectual disability (ID) in the offspring and 
second, the synergy between placental gene Forkhead box protein 1(FOXP1) and developmental 
delay (DD) in the offspring. We focused on assessing two specific paradigms, i) placental gene 
expressions of MeCP2 among children that have ID vs. children without ID; and ii) placental gene 
expression of FOXP1 among children that have DD vs. children without DD. We measured the 
presence and severity of ID using Full Scale Intelligence Quotient (FSIQ) derived from the 
Wechsler Preschool & Primary Scale of Intelligence IV (WPPSI-IV) as well as the presence and 
severity of DD using a composite score from Bayley Scales of Infant Development (Bayley-III) 
and examined gene expressions of MeCP2 and  FOXP1 in the placenta. Previous studies found 
concrete evidence that both MeCP2 and FOXP1 are implicated with neurodevelopmental disorders 
such as  ID and DD (Chahrour et al., 2008; Meerschaut et al., 2017). We proposed to test whether 
hyper expressions of those two genes (MeCP2 and FOXP1) in placenta will be associated with 
children that have higher intellectual and developmental scores. We further examined the influence 
of prenatal stress, as measured by exposure to Hurricane Sandy, on the relationship between the 
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placental expression of the two genes, and neurodevelopmental disorders ID and DD. A linear 
regression model demonstrated that there is a significant moderately positive correlation between 
MeCP2 gene expression and FSIQ score for children with ID. In contrast, we found that hyper-
expression of the FOXP1 gene was associated with lower scores on the three domains of DD: 
motor development, language development and general adaptive development areas. In addition, 
the magnitude of the association between FOXP1 and DD in areas of language and general 
adaptive development was different in relation to exposure to Hurricane Sandy among mothers 
during pregnancy. Children whose mothers were exposed to Hurricane Sandy on average had a 
hyper-FOXP1 expression along with lower DD score. This suggests that prenatal stress further 
aggravates the magnitude of the association between FOXP1 and DD. These results demonstrate 
the intricate roles of genes (MECP2 and FOXP1) and environment (Hurricane Sandy) on 
neurodevelopmental disorders (ID and DD). To further advance our understanding of MECP2, 
FOXP1, ID and DD, more studies should be conducted to examine the impact of specific mutations 
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 Several epidemiology models have described the interaction between genes and 
environmental factors using models that account for the way genetic outcomes can be modified by 
different types and levels of environmental exposure (Hunter, 2005). In the past century, a growing 
number of researchers have studied the impact of genes and environmental factors, both singly and 
jointly, on the functionality of the brain. From neurodevelopmental disorders in early years in life 
to cognitive decline in later years, there is a clear interrelation between genes, environmental 
disposition and diseases that attenuate the functionality of the brain (Lenroot & Giedd, 2008). It is 
well established that there is a strong linkage between the pathogenesis of neurodevelopmental 
disorders and epigenetics that is not a result of single mutation but alters gene expression patterns. 
Maternal factors during gestation have been shown to trigger epigenetic mechanisms that alter the 
expression of various placental genes. Those genes play a significant role in fetal development 
without causing mutation (Salilew-Wondim et al., 2014). In this study, we focused on assessing 
two specific paradigms, i) gene expressions of MeCP2 among children that have ID vs. children 
without ID; and ii) pattern of FOXP1 gene expressions among children that have DD vs. children 
without DD.   
Previous studies have shown evidence that both MeCP2 and FOXP1 are implicated in 
neurodevelopmental disorder such as  ID and DD (Chahrour et al., 2008; Meerschaut et al., 2017). 
As such, we examined expressions of those two genes collected and analyzed from the quadrant 
midway of mothers’ placenta, postpartum. We examined the influence of exposure to Hurricane 
Sandy on the relationship between the placental genes, MeCP2, FOXP1 and neurodevelopmental 
disorders, ID and DD. The group of mothers exposed to Hurricane Sandy included all mothers 
who were pregnant when Hurricane Sandy struck New York in 2012 (N=95).  
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Neurodevelopmental disorder is a collective term that denotes diagnostic outcomes 
resulting in abnormal brain development at the neonatal stage and cognitive impairment. This 
includes both structural defects such as neural tube defects and neuropsychological deficits such 
as impairments in motor and sensory organization, delayed speech and language, difficulties in 
learning, and other social interactions. These impairments can lead to disabilities that negatively 
affect the children’s quality of life (van Loo & Martens, 2007). 
 
The Placenta 
The placenta is an endocrine organ that connects maternal and fetal functions through a 
variety of biological pathways (Zhang et al., 2020a). It develops inside the uterus during pregnancy 
and is discharged shortly after birth (Garnica,et al., 1996). The health and functionality of the 
placenta is highly impacted by gene regulations, prenatal stress, maternal age, a break in water 
before labor, birth delivery method, high blood pressure, blood clotting disorder, previous uterine 
surgery, substance use, alcohol use, and abdominal trauma (Garnica & Chan, 1996; Key et al., 
2007a; Knopik et al., 2012; Martinelli et al., 2018; Zhang et al., 2020a). Of these, one of the most 
pertinent factors is prenatal stress, which can impact the function of the placenta. Specifically, 
prenatal stress can modify the placenta’s development during early pregnancy, alter  structures that 
might interfere blood flow to the placenta arteries or change gene expressions that might interrupt 
the functionality of vital proteins (Zhang et al., 2020a). Further, because of the dynamics of 
placental function and its key contribution to energy expenditure, gene expressions in the placenta 
are tightly regulated.  
The placenta has been shown to be affected by several maternal factors that lead to 
abnormal epigenetic regulation of various developmental genes such as MeCP2 and FOXP1.  This 
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abnormal epigenetic regulation may result in neurodevelopmental disorders in the offspring 
(Wilhelm-Benartzi et al., 2012). Epigenetic regulation of placental gene expression is achieved via 
one of the three mechanisms: i) DNA methylation; ii) circulation of microRNA; noncoding short 
RNAs that regulates mRNA expression; or iii) histone modification (Tsochandaridis et al., 2015; 
Vaiman, 2017). In this study, we will assess the contribution of prenatal stress (in terms of 
exposure to Hurricane Sandy) on the relationship between placental gene expressions of MECP2, 
FOXP1, and neurodevelopmental disorders, ID and DD, respectively.     
 
Intellectual Disability (ID) 
ID is the most common developmental disability affecting over 6.5 million Americans, in 
which approximately 545,000 are children between the ages of 6 and 21 years (Lee et al., 2021). 
ID is characterized by a significant limitation both in intellectual functioning and adaptive behavior 
in an individual. These limitations often lead to a range of  disadvantage to the individual’s daily 
life in personal and social functioning (Bach, 2007; Nagi, 1991; Oliver, 1996). Intellectual 
functioning describes the mental capability of an individual in the areas of reasoning, problem 
solving, planning, abstract thinking, judgment, comprehending complex ideas, learning rate, and 
learning from personal and societal experience, whereas adaptive behavior comprises conceptual, 
social, and practical skills that have been learned and performed by an individual with ID from 
people around his/her environment (Wechsler, 2012). The operational definition of ID and 
diagnostic criterial measures intellectual functioning and adaptive behavior (Schalock, 2015). 
In recent years, the term ID is widely used internationally and has replaced the previous 
term mental retardation, which has taken on a derogatory connotation. The new term, ID, better 
represents the multidimensionality of the disability. ID is operationally defined as having 
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significantly subaverage general intellectual functioning along with deficits in adaptive behavior 
that is manifested during the developmental period, that adversely affects a child’s quality of life. 
The diagnostic criteria of ID are deficit in intellectual functioning that results in an intellectual 
quotient (IQ) of 70 or below and deficit in adaptive behavior measured using standardized, 
culturally appropriate tests.  The current definition emphasizes the importance of the interaction 
between the person and their environment and the role that an individualized support system can 
play in enhancing individual functioning. ID also looks at the individual’s overall participation in 
a society: it analyzes the individual’s performances in actual activities, in social life domains and 
comfortability of the individual in a society. Furthermore, it assesses roles and interactions of an 
individual in the areas of home, work, education, leisure, spiritual, and cultural activities 
(Wehmeyer et al., 2008).  
Similarly, the etiology of ID is a multifactorial construct, that can change across  time. The 
updated etiology of ID replaces the old approach to diagnosis. In recent years, researchers have 
developed a more comprehensive criteria for etiology of ID by  dividing the etiology of ID into 
four  main risk factors categories – biomedical, social, behavioral and educational factors – that 
interact across time (Emerson et al., 2007). Biomedical factors are related to biologic processes, 
such as genetic disorders, nutrition, maternal illness, or parental age. Social factors look at social 
and family influences, such as poverty, maternal malnutrition, and adult responsiveness. 
Behavioral factors relate to potentially causal behaviors, such as treacherous activities or maternal 
substance abuse. And lastly, educational factors analyze the availability of educational supports 
promoting mental development and the development of adaptive skills (Walker et al., 2007). The 
etiology of ID provided a framework for screening variables in our study: independent variable 
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(gene expressions), moderating effector (prenatal stress – exposure to Hurricane Sandy)  and 
confounding variable (maternal age, smoking history, and education).  
Generally, contributing factors to ID include both environmental and personal factors. 
Environmental factors include physical, social and attitudinal ambience in which people live and 
conduct their daily lives. Personal factors are phenotypes and traits of the person such as genetic 
disposition, gender, race, age, coping styles, education, past and current experiences and struggles, 
resiliency, and psychological assets. Analyzing the interrelated environmental and personal factors 
in the individual’s everyday life produces a more detailed background of an individual’s life. This 
detailed information can help us understand the source of limitations and how it causes 
disadvantages to an individual (WHO, 2001). Limitations in all or any combination of these factors 
could play a key role in the manifestation of ID (Luckasson & Reeve, 2001; Schalock, 2015; 
Schalock et al., 2010).  
Assessment tools such as the Wechsler Preschool and Primary Scale of Intelligence 
(WPPSI) are designed to account for this multidimensionality and precisely evaluate the level and 
severity of ID. The Full-Scale Intelligence Quotient (FSIQ) section of the WPPSI probes ID via  
subtests in areas of  verbal comprehension, perceptual reasoning, working memory, and processing 
speed (Syeda & Climie, 2014; Wechsler, 2012). We used the WPPSI assessment to evaluate the 
presence and severity of ID in this study.  
 
Developmental Delay (DD) 
DD manifests when a child fails to reach developmental milestones due to impairments as 
compared to children in his/her age group. An array of impairments in motor, speech, language, 
cognitive performance, social, psychological, and general daily activity often are associated with 
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DD. Delay is often caused by biological factors, such as alteration in genes; delay can also be 
caused by environmental factors, such as maternal depression, maternal stress and/or maternal 
drug abuse (Choo et al., 2019; Ross et al., 2015).  
A standardized method to screen for DD is by looking at impairments in one of the four 
main domains. The first domain is gross and fine motor development which includes physical 
developments such as rolling over, sitting, standing, hopping, and unclenching fist voluntarily 
before the age of three months. Most clinicians and researchers assess fine motor function at early 
ages with a set of blocks to evaluate proper hand-mouth coordination. As the child gets older, areas 
of impairment are easier to assess more directly. By the age of 1.5 years, a baby should be able to 
play with blocks; by the time the baby reaches the age of 2 years, the baby should be able to 
assemble a short tower. A three-year-old should be able to make a tower of 6 to 8 blocks, a four-
year-old a tower of 10 blocks, and a five-year-old a complex building or staircase with the blocks 
(Chen, 1999). As the baby gets older, the height and the complexity of the tower should progress, 
as well.  
The second domain looks at language development. Language development encompasses 
the extent of the child's language performance, expressive as well as receptive, and the 
characteristics of the environment in which the child is learning a language. The developmental 
period from age 3 to 5 years old is a critical language learning time (Scarborough Hollis S. & 
Dobrich Wanda, 1990).  From birth to 5 months, a child should vocalize pleasure and displeasure 
sounds differently (laughs, giggles, cries, or fusses) and make noise when talked to. In the age 
range between 6 to 12 months, a child should understand the word “no”, bubbles random words 
without understanding the meaning such as “ba-ba-ba”, “ma-ma”, “da-da”, and attempts to repeat 
short words. From the age of 12 to 23 months, child should reach certain milestones such as answer 
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simple questions, expand vocabulary collection, ask for common foods by name and make animal 
sounds. In the age range between 2 to 4 years old, a child should comprehend spatial concepts, 
pronouns and descriptive words, answer to simple questions, form short sentences and repeat 
sentences. Between the age of 4 to 5 years, a child should understand complex questions and time 
sequences, deliver understandable speech with some pronunciation mistakes, express ideas and 
feelings, and use imagination to create stories (Luinge et al., 2006; Nelson et al., 2006).  
The third domain describes cognitive development. In the age range of newborn to 4 years 
old, motor and language milestones are often the best proxy to assess cognitive functionality. For 
example, from eight to nine months a child should comprehend object permanence. If a child 
cannot recognize that a hidden object is still present, the child might fail to make the appropriate 
mental connections. A child in the age range of 1 to 1.5 years old should begin to demonstrate an 
understanding of cause and effect:  parents should be asked whether the child loves to throw a toy 
down just so the parent can pick it up. Once the parent picks up the object, the child should have 
a positive reaction such as laughing, understanding that the cause of throwing the toy has an effect 
of the parent picking it up (Chen, 1999; Martin et al., 2012). As a child grows, increased attention 
to size and shape relations, symbolic thoughts and play, as well as the development of more formal 
language should indicate comprehension of both concrete and expanding abstract thinking 
(Mackrides & Ryherd, 2011a).  
The last domain is psychosocial development which covers behavioral abnormalities which 
could be a possible indicator of difficulties in emotional development. Although it is normal to 
have behavioral obstacles as a child, clinicians and parents must assess quantity, severity, nature, 
and duration of these episodes. Infants who refuse to eat, ruminate (chew excessively), or have an 
abnormal desire to eat substances not normally eaten, severe sleep disturbances, overexcitability, 
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or apathy, and toddlers and preschoolers with signs of extreme aggressiveness, fearfulness, or 
substantial defecation problems should be referred for psychological or behavioral testing (Chen, 
1999).  
In the United States alone, 12 to 16 percent of children have at least one type of 
developmental delay. However, 6 to 8 percent of the children with DD aren’t identified up until 
they enter kindergarten. Failure to identify DD during early infancy results in missed opportunities 
for effective intervention. The sooner DD is identified, the earlier an effective intervention can be 
implemented, and hence the higher the chance to reduce long-term disability due to DD (Mackrides 
& Ryherd, 2011b).  
The etiology of DD consists of three main risk factor categories: 1) biological risk factors 
which include  prenatal or perinatal insult, 2) environmental factors, and 3) established risks, such 
as clearly diagnosed disorder in infancy (Rihar et al., 2018). In addition, factors, such as low birth 
weight as a result of intraventricular hemorrhage, sepsis or meningitis, metabolic disturbances, and 
nutritional deficits can have a subsequent impact on brain growth (Tseng, 2017). Children at 
increased environmental risk include those whose mothers are young and inexperienced and those 
with limited financial and familial resources. Children living in families troubled by drugs, alcohol, 
and violence are particularly vulnerable to poor developmental outcome as well (Tseng et al., 2016; 
Wilder, 2015).   
In order to assess developmental delay in our study, we used data of children that had 
available developmental assessments from the Bayley-III. The Bayley-III is an individually 
administered instrument designed to assess the developmental functioning of infants, toddlers, and 




Gene 1: Methyl CpG Binding Protein 2 (MeCP2) 
MeCP2, first identified in 1992, is a protein that specifically binds symmetrically to only 
methylated DNA. The MeCP2 gene is highly conserved across mammals; samples from humans 
and mice (which diverged from common ancestors) showed a 95% homogeneity at the amino acid 
level (Guy et al., 2011). The high homogeneity allows researchers to manipulate the gene and 
generate mutation of MeCP2 in mouse models and draw a conclusion that can be closely translated 
to human body functions.  
In healthy cells, MeCP2 protein plays a transcriptional regulatory role through a 
mechanism that involves global binding to DNA and regulation of tertiary structures (Hite et al., 
2009). MeCP2 defines both structural and functional properties of neurons during the stages of 
neurodevelopment and adulthood. MeCP2 gene begins being expressed for the first time in mid-
gestation with a persistent high level of expression in mature neurons. The MeCP2 protein is highly 
abundant in the brain (Gulmez Karaca et al., 2019). In general, MeCP2 regulates brain 
development and maintains the function of mature neurons throughout adulthood. During early 
embryonic development, neuronal maturation, and circuit formation, MeCP2 monitors neuronal 
differentiation. When cells are undergoing the process of differentiation and maturation, MeCP2 
facilitates chromocenter clustering, therefore contributes adequately to the foundation of the 
typical chromatin structure of mature neurons (Gulmez Karaca et al., 2019). In adulthood, MeCP2 
is a critical factor in the maintenance of the neuronal function: it maintains the chromatin structure 
and regulates the neuronal transcriptomic profile (Adkins & Georgel, 2011). Moreover, it 
maintains permissive state for stimulus-dependent gene transcription and regulates cognitive 
function (Gulmez Karaca et al., 2019).  
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In a mouse model, via Cre recombinase-mediated excision of exon of MeCP2, scientists 
demonstrated the essential role of MeCP2 for embryo viability and placenta development.  
Multiple reports have illustrated that MeCP2 are abundantly expressed in the placenta (Itoh et al., 
2012). Collectively, these studies demonstrate the important role of MeCP2 gene in brain 
functions.  
Mutation in MeCP2 can cause other neurobehavioral abnormalities such as learning 
disability, autism, x-linked ID and infantile encephalopathy. In the classic case, a nonsense and 
missense mutation in a X-linked MeCP2 gene causes Rett syndrome, a severe and progressive 
neurodevelopmental disorder that is highly characterized by mild to profound ID (Gulmez Karaca 
et al., 2019). The x-linked mutation in mammals leads to different outcomes depending on gender. 
In general, x-linked MeCP2 mutations affect males much more severely than females due to 
hemizygosity (Guy et al., 2011). Surprisingly, a duplication and overexpression of MeCP2  also 
has been linked with equally detrimental damage to the brain functionality (Chahrour et al., 2008). 
 
Gene 2: Forkhead Box P1 (FOXP1) 
The FOXP1 gene belongs to the forkhead family of winged helix transcription factor genes.  
FOXP1, a transcriptional suppressor plays a vital role in the regulation of tissue and cell  specific 
gene transcription during developmental period and adulthood (Ferland et al., 2003). Via 
transcriptional repression mechanism, FOXP1 protein regulates embryogenesis and preserves 
differentiated tissue in the early stage of life. FOXP1 protein is expressed as early as gestational 
week 14 and persist into adulthood. FOXP1 is highly expressed in the developing and mature basal 
ganglia. A series of experiments found moderate gene expression of FOXP1 in the cerebral cortex 
(layers 3–5), hippocampus (CA1), and thalamus (Bacon et al., 2015).  FOXP1 protein is expressed 
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in distinct brain regions of developing bird, mice and human brains; these brain regions are 
associated with production and processing of vocalization and language (Hamdan et al., 2010).  
FOXP2, the closest forkhead family member to FOXP1 and with high homogeneity at 
amino acid level to FOXP1, was the first gene associated with pathogenesis of speech development 
and language disorder (Takahashi et al., 2013). The functional relationship between FOXP1 and 
FOXP2 and their role in pathogenesis of developmental language disorders has been described in 
many studies using mouse models and human subjects (Meerschaut et al., 2017).  
Mutation in the FOXP1 gene has been linked with neurodevelopmental disorders such as 
ID, autism spectrum disorder and developmental language disorder. These findings suggest that 
FOXP1 might have a key role in cognitive and social processes (Bacon et al., 2015). Some reports 
have shown that individuals with DD, ID, developmental speech and language disorders, autism 
spectrum disorder, and motor development delay demonstrated some type of FOXP1 mutation 
including specific deletions, nonsense mutations and chromosomal breakpoints that essentially led 
to interruption of protein functionality (Bacon et al., 2015; Le Fevre et al., 2013). Another study 
showed that mutation in FOXP1 causes intellectual disability and specific language disorder, along 
with or without autistic  traits. Patient with FOXP1 mutation also displayed neuromotor delay 
(Gheorghe et al., 2009).  
Transcription factor, FOXP1 has been associated with many recognizable cognitive 
phenotypes. In a study with humans, Meerschaut and her colleagues analyzed the correlation 
between 48 clinical patients with defected FOXP1 and their cognitive phenotype. The sample 
comprised molecular data of 25 novel and 23 previously reported patients with FOXP1 defects. 
The research evaluated FOXP1 activity using in vitro luciferase model and FOXP1 protein stability 
in vitro by western blot. All patients with defected FOXP1 showed ID, neuromotor delay, language 
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impairment along with behavioral problems and autistic traits. In a further analysis, severity of ID, 
neuromotor delay and language impairment varied depending on location of deletion of FOXP1: 
patients with interstitial 3p deletions (14 patients) had a more severe cognitive phenotype 
compared to patients with monogenic FOXP1 defects (34 patients).  
It is worth mentioning that both monogenic FOXP1 mutations and more extensive 3p 
chromosomal deletions surrounding FOXP1 were implicated with language disorder. Most of 
these mutations led to premature truncation and nonsense-mediated mRNA decay: only truncation 
resulted in nonfunctional protein. The most common disorder observed amongst the 48 subjects 
were developmental language delay, neuromotor delay and ID (Meerschaut et al., 2017).  
In a mouse model, FOXP1 mutant mice generated via Cre-lox system had significantly 
reduced striatum volume compared to wildtype mice. Mice with a mutation to FOXP1 show a 
reduction in the striatum and less densely packed neurons in CA1 of the hippocampus. These 
finding suggests that FOXP1 modulates striatum and CA1 functions. The striatum plays a key role 
in facilitating voluntary movement, such as motor and action planning, decision making, and 
speech movement and CA1 of the hippocampus is important for representing space in the 
environment: individual cells in CA1 are responsible for encoding for space and therefore long-
term memory for space and attentional modulation (Wolfgang, 2015, Kandel et al., 2014).  FOXP1 
mutant mice showed strikingly reduced exploratory behavior in all categories of the experiment: 
nest-building ability of FOXP1 knockout mice was drastically impaired, with no attempt made to 
construct a nest after nesting material was provided (Bacon et al., 2015). This finding suggests that 





Present Study Hypotheses 
Hypothesis 1: Studies have shown that the maternal factors during gestation trigger epigenetic 
mechanisms that may alter the expression of various placental genes that play a significant role in 
fetal development. There is a clear linkage between pathogenesis of neurodevelopmental disorders 
and epigenesis that do not result in a mutation, but rather alter the gene expression pattern (Salilew-
Wondim et al., 2014). Based on the literatures discussed above, we hypothesized that there is a 
positive linear relationship between  MeCP2 placental gene expression and FSIQ score in children 
with ID. Although, a lot of the past studies on MeCP2 and ID focused on the causal relationship 
between a specific type of mutation in MeCP2 and its detrimental impact on ID, this study focused 
on the correlative relationship between gene expression of MeCP2 and ID across generation. 
Hypothesis 2:  A mutation in FOXP1 has been implicated with pathogenesis of language, motor, 
social and cognitive delay. Although, a lot of the past studies on FOXP1 and DD focused on the 
causal relationship between a specific type of mutation in FOXP1 and its detrimental impact on 
DD, this study focused on the correlative relationship between gene expression of FOXP1 and DD 
across generation. Based on the literatures discussed in the DD and FOXP1 gene sections, we 
propose that there is a positive linear relationship between  FOXP1 gene expression and 
developmental scores in areas of language development, cognitive development, motor 









The Stress in Pregnancy (SIP) Study is an ongoing longitudinal study that investigates the impact 
of prenatal stress on child neurodevelopment. The participants are pregnant women recruited from 
the obstetrics clinics at Mount Sinai Hospital and New York Presbyterian/Queens in New York 
City. All recruited participants were at least in their second semester. All mothers were equipped 
with detailed follow-ups prospectively. For this study, a total of 275 participants were included in 
which placental biopsies were collected along with relevant delivery information (mode of 
delivery, use of assisted delivery devices, etc.). We restricted our analysis from the general SIP 
study participants to those that had available placental gene analysis and their offspring’s cognitive 
functioning scores from the WPPSI-IV and the Bayley-III assessments. After cross referencing the 
molecular data of mother’s placental gene analysis and offspring that have completed the WPPSI 
and the Bayley assessments, we had a total of 266 subjects (163 that have completed the WPPSI 
and 103 that had the Bayley assessments). Written consent was obtained from all participants and 
the study was approved by the Institutional Review Boards (IRB). 
Exclusion criteria: mothers were excluded from the study based on HIV infection, maternal 
psychosis, maternal age < 15 years, life-threatening maternal medical complications, and 
congenital or chromosomal abnormalities in the fetus.  
The mean age of mothers was 27 years old with standard deviation of 5.74 years. Among the 
offspring that completed the WPPSI or the BAYLEY, 48.4 % were female. The mothers were 
Hispanic/Latino (53%), Black (24%), White (9%), Asian (8%) and other (6%). Though 58% of 
mothers attended college, only 18% had completed a bachelor or graduate degree. A small 
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majority of mothers were single (57%), while 40% were married or in a common law marriage. 
34.4% (N = 95) of mothers were exposed to Hurricane Sandy: Of the 95 exposed mothers, 66 
participants experienced the storm during their first trimester and 29 mothers during the 2nd or 3rd 
trimesters.   
The Institutional Review Boards at the City University of New York, Icahn School of Medicine at 
Mount Sinai, and New York Presbyterian/Queens approved the study.  
Placenta accretion and gene expression analyzation: 
At delivery, researchers gathered medical birth records and collected placentas. Placenta biopsies, 
free of maternal decidua, were collected from each quadrant midway between the cord insertion 
and the placenta rim within one hour of delivery in order to prevent RNA degradation. The 
placentas were snap-frozen in liquid nitrogen and stored at -80 ̊C. RNA was extracted with the 
Maxwell 16 automated DNA/RNA extraction equipment, using the proprietary extraction kits 
following the manufacturer’s protocol. RNA was quantified with Nanodrop spectrophotometer at 
Thermo Electron North America in Madison, WI. Placental RNA was profiled using nCounter by 
NanoString Technologies in Seattle, WA. Nanostring data were normalized using the NanoString 
Norm package. First, raw code counts were normalized against the geometric mean of spike-in 
controls to account for differences in hybridization and recovery. Differences in sample content 
were accounted for by normalizing the data against the geometric mean of housekeeping genes 
(GAPDH, RPL19, and RPLP0). The background threshold was set to the limit of detection divided 






Wechsler Preschool and Primary Scale of Intelligence-IV (WPPSI-IV) 
The WPPSI-IV is a reliable and valid tool to measure the presence and severity of ID (Syeda & 
Climie, 2014)(Wechsler, 2012). The WPPSI measures overall intellectual disability on Full Scale 
Intelligence Quotient (FSIQ). The FSIQ measures an individual's overall level of general cognitive 
and intellectual functioning. In this study, we used FSIQ composite score derived from 
administration of subtests from the WPPSI to assess the presence and severity level of ID. Of the 
participants for whom placental genetic data was collected and analyzed, we only included 
placental gene expression analysis data for mothers who had corresponding assessments for their 
children - completed the test before seven years of age.  
The WPPSI is composed of multiple subtests to assess the intellectual ability and cognitive 
functioning of children as young as 2 years,6 months old to 7 years, 3 months old. The score 
summary is divided into five main domains which include FSIQ, Verbal IQ (VIQ), Performance 
IQ (PIQ), Processing Speed (PIQ), and Global Language (GLC). For the purpose of this specific 
study, we focused primarily on the FSIQ score, which is the most representative indicator of ID. 
The FSIQ provides us with a composite score of four different areas which include verbal 
comprehension, perceptual reasoning, working memory, and processing speed (Wechsler, 2012). 




Figure 1: Four Domains of FSIQ, and their prospective subsets. 
 
 
The WPPSI-IV is administered to two age groups: 2 ;6(indicates 2 years, 6 months)  to 3;7; vs. 4to 
7;7; . Subtest scores which were used to form the FSIQ score differed between the two-age group. 
For children in the age range of 2;6 to 3;7,  the FSIQ was based on five core subtests: Information, 
Receptive Vocabulary, Block Design, Object Assembly and Picture Memory. The subtests for this 
age range provides a more extensive measure of general intellectual functioning with the addition 
of Picture Memory which measures working memory. For children in the 4;0 to 7;7 age range, the 
FSIQ  score is based on six core subtests: Information, Similarities, Block Design, Matrix 
Reasoning, Picture Memory, and Bug Search. The subtests for this age range provides a more 
comprehensive measure of processing speed with the addition of Bug Search (Wechsler, 2012). 




Bayley Scales of Infant and Toddler Development Screening Test (Bayley-III) 
In order to assess developmental delay in our study, our analysis included children that had 
available developmental score from the Bayley-III. The Bayley-III is an individually-administered 
instrument designed to assess the developmental functioning of infants, toddlers, and young 
children aged between 1 and 42 months (Bayley & Aylward, 2019). The five main developmental 
domains assessed include cognitive, language, motor, adaptive, and socio-emotional development.  
Cognitive scale: encompasses a process by which knowledge is gained from perceptions or 
ideas. The cognitive scale assesses the child’s abilities in visualization, memory, and attention 
skills (Madaschi et al., 2016). Toddlers are examined on how they explore new toys, how they 
solve problems, and their learning process (Bayley & Aylward, 2019). 
Language scale: encompasses receptive communication (RC) and expressive communication 
(EC) to assess the child’s understanding of descriptive words, prepositions, and paralinguistic 
skills.  RC is assessed through tasks that measure the child’s ability to identify pictures, follow 
directions, and understand sizes/colors (Harman, 2010). EC is assessed through the child’s 
ability to use gestures, put words together in their native language, and their use of nonverbal 
expressions (Bayley & Aylward, 2019). 
Motor scale: the motor scale assesses both fine and gross motor abilities. Fine motor (FM) 
assesses the child’s ability to use their appendages to make things happen such as grabbing an 
object, stacking blocks, and drawing shapes. Gross motor (GM) assesses how well the child 
can move their body through sitting, walking, jump, and maintaining coordination (Bayley & 
Aylward, 2019).  
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Adaptive scale: the scale highlights how the child communicates their needs, crawls, plays, 
and how he/she is in their personal relationships and in socialization. The adaptive scale is 
primarily assessed through a questionnaire that the parent completes (Harman, 2010). 
Social-emotional development scale: The social-emotional scale is primarily assessed 
through a questionnaire that the parent completes. The scale consists of various items exploring 
the way in which the child reacts to his/her name, when interrupted in play, and their 
understanding of inhibitory words (Harman, 2010).  
The Bayley-III uses both raw and scaled scores as well as composite scores and percentile ranks 
for each domain. The standard score allows the examiner to measure the child’s development 
compared to other children his/her age and categorizes this into one of the seven levels. The seven 
levels include extremely low, borderline, low average, average, high average, superior and very 
superior (Madaschi et al., 2016). FSIQ score from the WPPSI has an identical break down of score 
to measure and assess the presence and severity of ID. In this study, we used the composite scores 
that is dissected as follow: 
Composite Score Classification 
130 and above Very Superior 
120-129 Superior 
110-119 High Average 
90-109 Average 
80-89 Low Average 
70-79 Borderline 
69 and below Extremely Low 





The magnitude of association between MeCP2 and ID was evaluated using a simple linear 
regression. A predictive model was then generated using the lm function, FSIQscore = α + 
β(MeCP2) + error. The α represents y-intercept and β represents the slope of the model.  In 
addition, we used an independent sample t-test to assess if there is a mean difference of MeCP2 
gene expression among children with ID vs. those without ID. Similarly, a linear regression model 
was also used to appraise the correlation between FOXP1 and DD. The predictive model estimated 
the presence and level of DD via the model, DDscore = α + β(FOXP1) + error. We also conducted 
an independent sample t-test to determine the significance of mean difference of FOXP1 gene 
expression between children with DD vs. children without DD. All regression models were then 
visualized using ggplot package in R-studio. A Secondary Analysis evaluated the moderating 
effect of exposure to Hurricane Sandy on the magnitude of association between placental genes 
MeCP2 and FOXP1, and neurodevelopmental disorders ID and DD, respectively via multiple 
linear regression model. We also evaluated the impact of certain confounding variables such as 
maternal age, smoking history, education and race via a multiple linear regression model. All 
confounding variables have been described in past studies as having an impact and/or an 
association with neurodevelopmental health of the offspring (Key et al., 2007b; Janecka et al., 








The Magnitude of Association between MeCP2 and ID 
Figure A shows a strong significant positive association between MeCP2 gene expression and 
FSIQ score among children with ID (N=36). Children with a FSIQ score of 70 or below were 
categorized as children with ID (figure 2). The graph demonstrates the variation of MeCP2 gene 
expression filtered by children with ID (turquoise shade) and without ID (light pink shade). For 
children with ID, the predictive model is FSIQscore = -339 + 47(MeCP2) + error with a p-value of 
0.028 and an adjusted R-squared value of 0.123. The slope is defined by 47 units: for every increase 
by 47 units in MeCP2, there is a one unit increase in FSIQ score. However, for a one-unit change 
in gene expression of MeCP2, a -292 FSIQ score is obtained which suggests that this is a non-
linear relationship. For children without ID (N=125), a weak non-significant positive correlation 
is observed between MeCP2 and FSIQ score among children without ID. The Moderating effect 
of Hurricane Sandy on the relationship between MeCP2 and ID was insignificant (p =0.069).  
Figure B demonstrates that children with ID have a higher average of MeCP2 gene expression 
compared to children without ID. An independent sample t-test was conducted to examine children 
with ID (x̅ = 8.16, σ= 0.267, N=37) and children without ID (x̅ = of 8.112, σ = 0.325, N=126) 
MeCP2 gene expression average. No significant difference was found  p = 0.446).   
The impact of Covariates on the relationship between MeCP2 and ID 
Maternal smoking had a significant effect on the magnitude of the association between MeCP2 
and FSIQ score; mothers that were smoking during pregnancy had a hypo-MeCP2 expression 
along with lower FSIQ score (p = 0.047, adjusted R2 = 0.163). Lastly, we adjusted the regression 
for maternal age and found a significant effect of maternal age on the relationship between MeCP2 
and FSIQ score. Mothers that were older than the age of 35, on average, had a lower MeCP2 
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expression and lower FSIQ score (p = 0.046, adjusted R2 = 0.165). There was no significant effect 
of race or education on the relationship between MeCP2 and FSIQ score. 
The Correlation between FOXP1 and Motor Developmental Score (MDS) 
For children with DD (N=35), those who had developmental score of 70 or less,  there is a negative 
correlation between gene expression of FOXP1 and MDS with an adjusted R-squared of 0.345 and 
a p-value of 0.034. The predictive model generated for this relationship is, MDS= 126-
8.50(FOXP1) + error. A slope of -8.50 indicates that as FOXP1 expression decreases by 8.50 units, 
there is an increase in motor development score by one unit (Figure C).  Exposure to Hurricane 
Sandy didn’t have a significant moderating effect on the relationship between FOXP1 and MDS. 
However, when adjusted for smoking history, there was a significant interaction between mothers 
that smoked during pregnancy, FOXP1 expression and MDS with  (p-value = 0.030, adjusted R2 
= 0.569). This suggests that mothers that were smoking during pregnancy had a stronger negative 
impact on the correlation between FOXP1 and motor development score: a higher FOXP1 
expression was associated with a lower MDS, on average. Figure D displays that the average 
FOXP1 gene expression for children with motor DD is higher than children without motor DD. 
An independent sample t-test was conducted to examine children with DD in motor area (x̅= 6.54, 
σ = 0.52) and children without DD in motor area (x̅= 6.45, σ= 0.49) FOXP1 gene expression. No 
significant difference was observed (pe = 0.55).  
The Magnitude of Correlation between FOXP1 and General Adaptive Score (GAS) 
Looking at general adaptive development, there was a strong magnitude of association between 
GAS and FOXP1 gene expression (p = 0.026, adjusted R2 = 0.380). A slope of -9.54 in Figure E 
demonstrates a negative correlation between FOXP1 and GAS for children with DD. Figure F 
displays that children with DD in general adaptive domain (x̅ =6.604, σ= 0.454) had hyper- FOXP1 
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gene expression compared to children without DD (x̅ =6.441303, σ= 0.495). The mean difference 
was not significant (p = 0.301).  
 
The Magnitude of Association between FOXP1 and Language Developmental Score (LDS) 
We also observed a significant negative correlation between language development score and 
FOXP1 gene expression (p = 0.033; adjusted R-squared = 0.132). Figure G shows a slope of -
5.649, displaying an inverse relationship between FOXP1 and language development score among 
children with DD. For mothers exposed to Superstorm Sandy, there was a significant moderating 
effect of environmental factor on the relationship between FOXP1 and LDS with a slope of -27 
 (p = 1.382e-05). In Figure H, a hyper-FOXP1 mean was observed for children with LDS (x̅ 
=6.509, σ =0.402) compared to children without LDS (x̅ =6.451, σ =0.523). However, an 
























Table 1. Demographic characteristics of participants 
  Superstorm Sandy exposure status  
















White 27 (9%) 15 ((7%) 12 (13%) 
Black 74 (25%) 58 (28%) 16 (17%) 
Hispanic/Latino 159 (53%) 111 (53%) 48 (51%) 
Asian 23 (7.7%) 10 (5%) 13 (14%) 
Others 14(4.68%) 13 (6%) 5(5%) 
Missing 2 (0.69%) 1 (~0%) 1 (1%) 









Primary school 6 (2.3%) 5 (2%) 1 (1%) 
Some high school 53(17%) 47 (23%) 6 (6%) 
High school graduate 68(22%) 48 (23%) 20 (21%) 
Some college 91(30%) 66 (32%) 25 (26%) 
Associate degree 30 (9.9%) 16 (8%) 14 (15%) 
Bachelor’s degree 30 (9.9%) 14 (7%) 16 (17%) 
Graduate degree 25(8.5%) 12 (6%) 13 (14%) 








Married 101 (33%) 50 (24%) 51 (54%) 
Common law 21 (7%) 14 (7%) 7 (7%) 
Single 173(57%) 140(67%) 34 (36%) 
Widowed 2 (1%) 2(1%) 0 (0%) 
Divorced/separated 3 (1%) 1 (.5%) 2 (2%) 
Missing 2 (1%) 1 (.5%) 1 (1%) 
Child sex, male, N (%) 158(52%) 94(59%) 64(41%) F= 2.249 
Maternal age, Mean (SD) 27(5.74) 27(6.1) 27(5.13) F=0.7304 
Birthweight (grams), Mean (SD) 3268(594) 3308(643) 3211(536) F=14.83 
Gestational age at birth (weeks), Mean 
(SD) 
39.2(2.07) 39.2(2.22) 39.04(2.02) F= 2.879 
Maternal prenatal smoking, N (%) 24(12.8%) 6(0.25%) 18(0.75%) X2(1)= 1.112 
p-value = 0.292 






The Influence of FOXP1 Gene on Motor Development 
 
Figure C shows the association between FOXP1 gene expression and motor development composite score for children 
with DD (turquoise, TRUE) and without DD  (light pink, FALSE). Figure D compares the mean value of FOXP1 gene 
expression among children with DD and children without DD in motor developmental area. 
 
MeCP2 Gene Expression Among Children with ID and without ID 
 
 
Figure A: The magnitude of association between MeCP2 gene expression  and FSIQ score among children 
with ID (turquoise, TRUE) and children without (light pink, FALSE). Figure B compares the mean MeCP2 











The Association between FOXP1 and General Adaptive Development 
 
Figure E: a linear regression demonstrating the association between FOXP1 gene expression and 
General Adaptive neurodevelopment score among children with DD (turquoise, TRUE) vs. children without DD(light 
pink, FALSE). Figure F: comparison of mean of FOXP1 gene expression among children with general adaptive DD 











The Role of FOXP1 Gene on Language Development 
 
 
Figure G a linear regression demonstrating the association between FOXP1 gene expression among children with DD 
in  Language development score (turquoise, TRUE) vs. children without DD(light pink, FALSE). Figure H: comparison 












Discussion and Conclusion 
Our results showed a significant association between MeCP2 gene expression and FSIQ 
score of children with ID. We observed a positive strong correlation between MeCP2 gene 
expression and FSIQ score of children with ID, and a non-significant association between MeCP2 
gene expression and children without ID (Figure A).  MeCP2 is a critical factor in the maintenance 
of the neuronal function; it maintains the chromatin structure and regulates the neuronal 
transcriptomic profile,  playing a vital role in pathogenesis of many neurodevelopmental disorders 
including ID. The observed result from this study supports our hypothesis and aligns with previous 
studies. Hyper-MeCP2 gene expression was associated with higher developmental score among 
children with ID.  
This study focused on the correlative relationship between placental gene expression of 
MeCP2, FOXP1 and neurodevelopmental disorder of ID and DD, respectively. We had no 
molecular data on mutation of these genes, we simply assessed the magnitude of association 
between gene expressions of  MeCP2, FOXP1 and neurodevelopmental disorders, ID and DD. 
However, this study is unique in that it compared maternal placental gene expressions with 
diagnosis of the offspring as ID or DD. Past studies discussed in the introduction section focused 
on MeCP2 and FOXP1 mutations in patients and presence and severity of ID and DD in the same 
patients. This study assessed the role of placental gene expression on neurodevelopmental disorder 
across generation: placental genes from the mother and ID and DD diagnoses from the offspring. 
The main rationale for this approach is that the candidate gene expressions were from a specific 
organ that connects and shapes multiple biological mechanisms between mother and offspring, the 
placenta.   
 
28 
The maternal factors during gestation trigger epigenetic mechanisms that may alter the 
expression of various placental genes that play a significant role in fetal development (Salilew-
Wondim et al., 2014). The placenta has been shown to be affected by environmental factors, 
leading to abnormal epigenetic regulation of various developmental genes; this abnormal 
regulation may result in neurodevelopmental disorders in the offspring (Wilhelm-Benartzi et al., 
2012).  
There are several epigenetics mechanisms that alter gene expression pattern without 
altering the DNA sequence via mechanisms such as DNA methylation, post-translational 
modifications of histone proteins, and transcriptional regulation by non-coding RNAs including 
miRNA, siRNA, piRNA (Cedar & Bergman, 2011). In addition, several reports have shown that 
the  process of early embryonic development in the fetus is highly susceptible to epigenetic 
modulation ((Reik et al., 1993; Resendiz et al., 2014). It is well established that there is a clear link 
between pathogenesis of neurodevelopmental disorders and epigenesis that does not result in a 
single mutation but, rather, alters gene expression pattern. Therefore, in this study, we focused on 
assessing two specific paradigms, i) the placental gene expression pattern of MeCP2 among 
children that have ID vs. children without ID, ii) pattern of FOXP1 gene expression among 
children that have DD vs. children without DD.  
The main limitation in the manipulation of this study is that we assessed maternal gene 
expression patterns among offspring with DD and ID subjects instead of a specific mutation. A 
future direction of this study will evaluate the relationship between maternal placental gene 
expression of MeCP2 and FOXP1. This evaluation will  include specific mutations of MeCP2 and 
FOXP1genes and their offspring’s ID and DD scores. An expansion of this study would involve 
recruiting mothers that have a nonsense or missense mutation in MeCP2 gene of the placenta and 
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evaluating whether their offspring are at higher risk for ID. In a parallel study, mothers with a 
placental 3p deletions or monogenic FOXP1 mutation would have their offspring evaluated for 
any signs of developmental delay. Such studies will allow us to evaluate whether MeCP2 and 
FOXP1 mutations in maternal placenta can cause neurodevelopmental disorders (ID, DD) in 
children; it will allow us to assess impact of epigenesis across generation, from mother to offspring.  
The FOXP1 gene expression pattern was significant among children that have DD in three 
specific developmental domains: motor development, language development and general adaptive 
development areas. All three developmental areas had a moderate to strong negative correlation 
with FOXP1 gene expression among children that have DD. No significant association was 
observed between FOXP1 gene expression and developmental areas in children without DD. We 
did not expect to find a negative correlation between FOXP1 gene expression and DD children. 
On average children with lower score in motor, language and general adaptive developmental areas 
had a hyper-FOXP1 expression. These findings neither support our hypothesis nor align with 
findings from past literature on function of FOXP1. We expected that higher gene expression of 
FOXP1 would be correlated with higher developmental scores.  
This unexpected inverse linear relationship between FOXP1 gene expression and DD 
scores could be accounted for by the small sample size we had for children with DD. Even though 
we had adequate data from mothers regarding placental gene expression, too few of the  offspring 
in the sample had a DD assessment. To confirm our findings, we suggest replicating a similar study 
with a much larger sample size of children with DD.  
For  FOXP1, we  observed higher mean gene expression average for DD group than non-
DD group. Again, considering that mutation of FOXP1 causes delays in language, motor and 
intellectual functions, we were surprised that children with DD had higher gene expression of 
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FOXP1 on average. We expected to find  that, on average, children without DD will have a higher 
expression of FOXP1 that children with DD. However, an independent sample t-test showed that 
this mean difference was not significant.  
A future study should assess whether there is a specific range of FOXP1 gene expression 
that is correlated with DD vs. non-DD. Similarly, expression of MeCP2 was higher among children 
with ID vs non-ID. We found, on average, hyper- MeCP2 among children with ID. There are some 
studies that reported on the relationship between overexpression of MeCP2 with ID: more analysis 
needs to be done but our result does coincide with these findings (Chahrour et al., 2008). More 
study needs to be done to evaluate, i) what qualifies as overexpression of MeCP2, ii) what impact 
does placental overexpression of MeCP2 has on offspring neurodevelopment.  
The impact of Hurricane Sandy on the relationship between placental genes and 
neurodevelopmental disorder was significant in almost all models. The correlative relationship 
between placental genes and neurodevelopmental disorders was more pronounced (in the direction 
of the findings from the primary analysis) in mothers that were exposed to Hurricane Sandy. These 
finding are parallel with previous findings on the influence of environmental factors on genes and 
pathogenesis of diseases. This study design was not able to address whether these environmental 
factors had a causal role in on the relationship between placental genes and neurodevelopmental 
disorders. Hurricane Sandy had the most moderating effect on the magnitude of association 
between FOXP1 gene expression and language DD; it’s worth noting that the sample size for the 
children identified with DD (N= 29) that also had mothers exposed to Hurricane Sandy was the 
greatest sample size compared to other groups. This observation suggests that a bigger sample size 
of mothers that were exposed to Hurricane Sandy is needed to accurately evaluate the moderating 
effect of prenatal stress on the magnitude association between gene expressions and 
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neurodevelopmental disorders. In groups where we didn’t see a significant impact of prenatal 
stress (exposure to Hurricane Sandy), the sample size was very small. There appeared to be a 
moderating effect of Hurricane Sandy on the association between hypo-MeCP2 expression and 
lower FSIQ scores, but the statistical modeling indicated that this effect was not significant. 
However, it is not clear if this is due to a small sample size or actual lack of association.  Notably, 
there was only 5 cases of ID among children whose mothers were exposed to Hurricane Sandy.  
The biggest limitation of this study is a small sample size; our sample size was restricted 
only to SIP study patients. A correlative study such as this one would be much stronger with data 
across the nation instead of a data that is restricted only to participants from Mount Sinai Hospital 
and New York Presbyterian/Queens Hospital in New York City. Although, we started out with 
275 participants that had placental gene analysis, when we cross referenced and merged the 
molecular data on placental genes with the children who had also completed the WPPSI or the 
Bayley-III assessment, our sample size was significantly reduced.  A great expansion of this study 
would be a meta-analysis study that investigates the association between placental gene 
expressions and neurodevelopmental disorder across the nation or even the world.  
ID and DD are amongst the most common neurodevelopmental disorders in American. 
Both ID and DD generate limitations that interrupts many aspects of individual daily life. These 
limitations often lead to a range of disadvantage for the individual, posing obstacles and challenges 
in the individual’s daily life in personal functioning and performance of roles and tasks that are 
expected of an individual within a social environment.  
Over 6.5 million Americans have mild to severe ID and about 6 to 8 percent of the entire 
population have some form of DD. These numbers are alarming. A number of reports have shown 
that there is a clear link between epigenetic regulation and neurodevelopmental disorders such as 
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ID and DD. Dissecting the relationship between environmental factors, genes and 
neurodevelopmental phenotypical outcome is an important step in understanding this complex 
association. Advancing our understanding of this intricate relationship can help us identify risk 
factors for ID and DD. Subsequently, identifying risk factors allows parents and clinicians to 
implement certain interventions and measures that could potentially reduce disabilities and delays 
in a child’s life. Collectively, as a society we should began focusing on the impact epigenetics as 
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